MASS MEGAWATTS WIND POWER INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MASS MEGAWATTS WIND POWER INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Apr 30, 2013 | $0 | Aug 9, 2013 |
| FY2012 | Apr 30, 2012 | $12.4K | Jul 30, 2012 |
| FY2012 | Apr 30, 2011 | $0 | Jul 30, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | ($347.2K) | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | ($285.4K) | Jul 25, 2023 |
| FY2022 | Apr 30, 2021 | ($284.5K) | Jul 29, 2022 |
| FY2014 | Apr 30, 2014 | ($455.7K) | Aug 13, 2014 |
| FY2014 | Apr 30, 2013 | ($429.1K) | Aug 13, 2014 |
| FY2013 | Apr 30, 2012 | ($396.1K) | Aug 9, 2013 |
| FY2012 | Apr 30, 2011 | ($472.9K) | Jul 30, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Apr 30, 2014 | ($442.9K) | Aug 13, 2014 |
| FY2014 | Apr 30, 2013 | ($415.4K) | Aug 13, 2014 |
| FY2013 | Apr 30, 2012 | ($382.4K) | Aug 9, 2013 |
| FY2012 | Apr 30, 2011 | ($472.7K) | Jul 30, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Apr 30, 2013 | $13.4K | Aug 9, 2013 |
| FY2013 | Apr 30, 2012 | $14.6K | Aug 9, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | ($198.5K) | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | ($285.4K) | Jul 25, 2023 |
| FY2022 | Apr 30, 2021 | ($161.8K) | Jul 29, 2022 |
| FY2014 | Apr 30, 2014 | ($229.3K) | Aug 13, 2014 |
| FY2014 | Apr 30, 2013 | ($286.3K) | Aug 13, 2014 |
| FY2013 | Apr 30, 2012 | ($262.6K) | Aug 9, 2013 |
| FY2012 | Apr 30, 2011 | ($445.1K) | Jul 30, 2012 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Apr 30, 2013 | $0 | Aug 9, 2013 |
| FY2012 | Apr 30, 2012 | $8.7K | Jul 30, 2012 |
| FY2012 | Apr 30, 2011 | $0 | Jul 30, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | $2.8K | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | $108.9K | Jul 25, 2023 |
| FY2022 | Apr 30, 2021 | $71.7K | Jul 29, 2022 |
| FY2014 | Apr 30, 2014 | $29.7K | Aug 13, 2014 |
| FY2014 | Apr 30, 2013 | $32.2K | Aug 13, 2014 |
| FY2013 | Apr 30, 2012 | $51.7K | Aug 9, 2013 |
| FY2012 | Apr 30, 2011 | $34.0K | Jul 30, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | $272.7K | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | $126.6K | Jul 25, 2023 |
| FY2022 | Apr 30, 2021 | $128.6K | Jul 29, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | ($269.9K) | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | ($17.7K) | Jul 25, 2023 |
| FY2023 | Apr 30, 2021 | ($56.9K) | Jul 25, 2023 |
| FY2022 | Apr 30, 2020 | ($616.0K) | Jul 29, 2022 |
| FY2014 | Apr 30, 2014 | ($193.4K) | Aug 13, 2014 |
| FY2014 | Apr 30, 2013 | ($146.0K) | Aug 13, 2014 |
| FY2014 | Apr 30, 2012 | ($49.3K) | Aug 13, 2014 |
| FY2013 | Apr 30, 2011 | ($20.9K) | Aug 9, 2013 |
| FY2012 | Apr 30, 2010 | $151.9K | Jul 30, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | ($8.89M) | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | ($8.55M) | Jul 25, 2023 |
| FY2022 | Apr 30, 2021 | ($8.26M) | Jul 29, 2022 |
| FY2014 | Apr 30, 2014 | ($7.32M) | Aug 13, 2014 |
| FY2014 | Apr 30, 2013 | ($6.87M) | Aug 13, 2014 |
| FY2013 | Apr 30, 2012 | ($6.44M) | Aug 9, 2013 |
| FY2012 | Apr 30, 2011 | ($6.04M) | Jul 30, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | 0 | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | 0 | Jul 25, 2023 |
| FY2022 | Apr 30, 2021 | 0 | Jul 29, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | 0 | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | 0 | Jul 25, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | 152.29M | Jul 25, 2023 |
| FY2023 | Apr 30, 2022 | 138.36M | Jul 25, 2023 |
| FY2022 | Apr 30, 2021 | 128.96M | Jul 29, 2022 |
| FY2014 | Apr 30, 2014 | 43.18M | Aug 13, 2014 |
| FY2014 | Apr 30, 2013 | 25.73M | Aug 13, 2014 |
| FY2013 | Apr 30, 2012 | 17.07M | Aug 9, 2013 |
| FY2012 | Apr 30, 2011 | 8.91M | Jul 30, 2012 |